Design and clinical pilot testing of the model-based Dynamic Insulin Sensitivity and Secretion Test (DISST)

Journal of Diabetes Science and Technology

Volumn 4, Issue 6, 2010, Pages 1408-1423

  Lotz, Thomas F ^a   Chase, J Geoffrey ^a   McAuley, Kirsten A ^b   Shaw, Geoffrey M ^c,d   Docherty, Paul D ^a   Berkeley, Juliet E ^d   Williams, Sheila M ^b   Hann, Christopher E ^a   Mann, Jim I ^b  

^a UNIVERSITY OF CANTERBURY   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c CHRISTCHURCH HOSPITAL   (New Zealand)

^d UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Insulin resistance; Insulin sensitivity; Physiological modeling; Pilot study; Type 2 diabetes diagnosis

Indexed keywords

BIOLOGICAL MARKER; C PEPTIDE; DIAGNOSTIC AGENT; GLUCOSE; INSULIN;

ADULT; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; INSULIN RESISTANCE; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; NEW ZEALAND; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS; PATHOPHYSIOLOGY; PILOT STUDY; PREDICTIVE VALUE; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; SECRETION; TIME;

ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; C-PEPTIDE; DIABETES MELLITUS, TYPE 2; FEASIBILITY STUDIES; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; NEW ZEALAND; PANCREAS; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; TIME FACTORS; YOUNG ADULT;

EID: 79953012398     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681000400616     Document Type: Article

References (57)

1. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14(3):173-94.
2. Ferrannini E. Insulin resistance is central to the burden of diabetes. Diabetes Metab Rev. 1997;13(2):81-6.
3. Martin BC, Warram JH, Krolewski AS, Bergman R, Soeldner JS, Kahn CR. Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet. 1992;340(8825):925-9.
4. McLaughlin T, Abbasi F, Lamendola C, Reaven G. Heterogeneity in prevalence of risk factors for cardiovascular disease and type 2 diabetes in obese individuals: effect of differences in insulin sensitivity. Arch Intern Med. 2007;167(7):642-8.
5. Scheen AJ, Paquot N, Castillo MJ, Lefebvre PJ. How to measure insulin action in vivo. Diabetes Metab Rev. 1994;10(2):151-88.
6. Radziuk J. Insulin sensitivity and its measurement: structural commonalities among the methods. J Clin Endocrinol Metab. 2000;85(12):4426-33.
7. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237(3):E214-23.
8. Ferrannini E, Mari A. How to measure insulin sensitivity. J Hypertens. 1998;16(7):895-906.
9. Bonora E, Moghetti P, Zancanaro C, Cigolini M, Querena M, Cacciatori V, Corgnati A, Muggeo M. Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies. J Clin Endocrinol Metab. 1989;68(2):374-8.
10. Pacini G, Bergman RN. MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput Methods Programs Biomed. 1986;23(2):113-22.
11. Saad MF, Anderson RL, Laws A, Watanabe RM, Kades WW, Chen Y, Sands RE, Pei D, Savage PJ, Bergman RN. A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Diabetes. 1994;43(9):1114-21.
12. Galvin P, Ward G, Walters J, Pestell R, Koschmann M, Vaag A, Martin I, Best JD, Alford F. A simple method for quantitation of insulin sensitivity and insulin release form an intravenous glucose tolerance test. Diabet Med. 1992;9(10):921-8.
13. Caumo A, Vicini P, Zachwieja JJ, Avogaro A, Yarasheski K, Bier DM, Cobelli C. Undermodeling affects minimal model indexes: insights from a two-compartment model. Am J Physiol. 1999;276(6 Pt 1):E1171-93.
14. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-9.
15. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85(7):2402-010.
16. American Diabetes Association. Economic consequences of diabetes mellitus in the U.S. in 1997. Diabetes Care. 1998;21(2):296-309.
17. McAuley KA, Mann JI, Chase JG, Lotz TF, Shaw GM. Point: HOMA - Satisfactory for the time being: HOMA: the best bet for the simple determination of insulin sensitivity, until something better comes along. Diabetes Care. 2007;30(9):2411-3.
18. Lotz T, Chase JG, McAuley KA, Shaw GM, Wong J, Lin J, Lecompte A, Hann CE, Mann JI. Monte Carlo analysis of a new model-based method for insulin sensitivity testing. Comput Methods Programs Biomed. 2008;89(3):215-25.
19. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2006;29(Suppl 1):S43-S48.
20. Lotz T, Chase JG, Lin J, Wong XW, Hann CE, McAuley KA, Andreassen S, editors. Integral-based identification of a physiological insulin and glucose model on euglycaemic clamp trials. In: 14th IFAC Symposium on System Identification (SYSID 2006); 2006 Mar 29-31; Newcastle, Australia: IFAC; 2006.
21. Lotz T. High resolution clinical model-based assessment of insulin sensitivity [Ph.D. Thesis]. Christchurch, New Zealand: University of Canterbury; 2007.
22. Edsberg B, Herly D, Hildebrandt P, Kuhl C. Insulin bolus given by a sprinkler needle: effect on absorption and glycaemic response to a meal. Br Med J (Clin Res Ed). 1987;294(6584):1373-6.
23. Cobelli C, Pacini G, Toffolo G, Saccà L. Estimation of insulin sensitivity and glucose clearance from minimal model: new insights from labeled IVGTT. Am J Physiol. 1986;250(5 Pt 1):E591-8.
24. Krudys KM, Kahn SE, Vicini P. Population approaches to estimate minimal model indexes of insulin sensitivity and glucose effectiveness using full and reduced sampling schedules. Am J Physiol Endocrinol Metab. 2006;291(4):E716-23.
25. Prigeon RL, Røder ME, Porte D Jr, Kahn SE. The effect of insulin dose on the measurement of insulin sensitivity by the minimal model technique. Evidence for saturable insulin transport in humans. J Clin Invest. 1996;97(2):501-7.
26. Chase JG, Shaw GM, Lin J, Doran CV, Bloomfield M, Wake GC, Broughton B, Hann C, Lotz T. Impact of insulin-stimulated glucose removal saturation on dynamic modelling and control of hyperglycaemia. IJISTA. 2004;1(1/2):79-94.
27. Chase J, Shaw GM, Wong XW, Lotz T, Lin J, Hann CE. Model?based glycaemic control in critical care - a review of the state of the possible. Biomed Signal Process Control. 2006;1(1):3-21.
28. Greisen J, Juhl CB, Grøfte T, Vilstrup H, Jensen TS, Schmitz O. Acute pain induces insulin resistance in humans. Anesthesiology. 2001;95(3):578-84.
29. Minaker KL, Flier JS, Landsberg L, Young JB, Moxley RT, Kingston WJ, Meneilly GS, Rowe JW. Phenytoin-induced improvement in muscle cramping and insulin action in three patients with the syndrome of insulin resistance, acanthosis nigricans, and acral hypertrophy. Arch Neurol. 1989;46(9):981-5.
30. Van Cauter E, Polonsky KS, Scheen AJ. Roles of circadian rhythmicity and sleep in human glucose regulation. Endocr Rev. 1997;18(5):716-38.
31. Hollenbeck CB, Reaven G. Treatment of patients with non?insulin?dependent diabetes mellitus: diabetic control and insulin secretion and action after different treatment modalities. Diabet Med. 1987;4(4):311-6.
32. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354(5):449-61.
33. Trout KK, Homko C, Tkacs NC. Methods of measuring insulin sensitivity. Biol Res Nurs. 2007;8(4):305-18.
34. Nishida Y, Tokuyama K, Nagasaka S, Higaki Y, Shirai Y, Kiyonaga A, Shindo M, Kusaka I, Nakamura T, Ishibashi S, Tanaka H. Effect of moderate exercise training on peripheral glucose effectiveness, insulin sensitivity, and endogenous glucose production in healthy humans estimated by a two-compartment-labeled minimal model. Diabetes. 2004;53(2):315-20.
35. O'Gorman DJ, Karlsson HK, McQuiad S, Yousif O, Rahman Y, Gasparro D, Glund S, Chibalin AV, Zierath JR, Nolan JJ. Exercise training increases insulin-simulated glucose disposal and GLUT4 (SLC2A4) protein content in patients with type 2 diabetes. Diabetologia. 2006;49(12):2983-92.
36. Hann CE, Chase JG, Lin J, Lotz T, Doran CV, Shaw GM. Integral-based parameter identification for long-term dynamic verification of a glucose-insulin system model. Comput Methods Programs Biomed. 2005;77(3):259-70.
37. Jefferson LS, Cherrington A. The endocrine pancreas and regulation of metabolism. Goodman HM, editor. New York: Oxford University Press; 2001.
38. Hauschke D, Kieser M, Diletti E, Burke M. Sample size determination for proving equivalence based on the ratio of two means for normally distributed data. Stat Med. 1999;18(1):93-105.
39. Bergman RN, Ider YZ, Bowden CR, Cobelli C. Quantitative estimation of insulin sensitivity. Am J Physiol. 1979;236(6):E667-77.
40. Callegari T, Caumo A, Cobelli C. Bayesian two-compartment and classic single-compartment minimal models: comparison on insulin modified IVGTT and effect of experiment reduction. IEEE Trans Biomed Eng. 2003;50(12):1301-9.
41. Regittnig W, Trajanoski Z, Leis HJ, Ellmerer M, Wutte A, Sendlhofer G, Schaupp L, Brunner GA, Wach P, Pieber TR. Plasma and interstitial glucose dynamics after intravenous glucose injection: evaluation of the single-compartment glucose distribution assumption in the minimal models. Diabetes. 1999;48(5):1070-81.
42. Caumo A, Vicini P, Cobelli C. Is the minimal model too minimal? Diabetologia. 1996;38(8):997-1000.
43. Caumo A, Cobelli C. Hepatic glucose production during the labeled IVGTT: estimation by deconvolution with a new minimal model. Am J Physiol. 1993;264(5 Pt 1):E829-41.
44. Hovorka R, Shojaee-Moradie F, Carroll PV, Chassin LJ, Gowrie IJ, Jackson NC, Tudor RS, Umpleby AM, Jones RH. Partitioning glucose distribution/transport, disposal, and endogenous production during IVGTT. Am J Physiol Endocrinol Metab. 2002;282(5):E992-1007.
45. Quon MJ, Cochran C, Taylor SI, Eastman RC. Non-insulin-mediated glucose disappearance in subjects with IDDM. Discordance between experimental results and minimal model analysis. Diabetes. 1994;43(7):890-6.
46. Del Prato S, Matsuda M, Simonson DC, Groop LC, Sheehan P, Leonetti F, Bonadonna TC, DeFronzo RA. Studies on the mass action effects of glucose in NIDDM and IDDM: evidence for glucose resistance. Diabetologia. 1997;40(6):687-97.
47. Best JD, Kahn SE, Ader M, Watanabe RM, Ni TC, Bergman RN. Role of glucose effectiveness in the determination of glucose tolerance. Diabetes Care. 1996;19(9):1018-30.
48. Vicini P, Caumo A, Cobelli C. Glucose effectiveness and insulin sensitivity from the minimal models: consequences of undermodeling assessed by Monte Carlo simulation. IEEE Trans Biomed Eng. 1999;46(2):130-7.
49. Vella A, Reed AS, Charkoudian N, Shah P, Basu R, Basu A, Joyner MJ, Rizza RA. Glucose-induced suppression of endogenous glucose production: dynamic response to differing glucose profiles. Am J Physiol Endocrinol Metab. 2003;285(1):E25-30.
50. Gudbjörnsdóttir S, Sjöstrand M, Strindberg L, Wahren J, Lönnroth P. Direct measurements of the permeability surface area for insulin and glucose in human skeletal muscle. J Clin Endocrinol Metab. 2003;88(10):4559-64.
51. Sjöstrand M, Holmäng A, Lönnroth P. Measurement of interstitial insulin in human muscle. Am J Physiol. 1999;276(1 Pt 1):E151-4.
52. Toffolo G, Campioni M, Basu R, Rizza RA, Cobelli C. A minimal model of insulin secretion and kinetics to assess hepatic insulin extraction. Am J Physiol Endocrinol Metab. 2006;290(1):E169-E176.
53. Thorsteinsson B. Kinetic models for insulin disappearance from plasma in man. Dan Med Bull. 1990;37(2):143-53.
54. Ferrannini E, Wahren J, Faber OK, Felig P, Binder C, DeFronzo RA. Splanchnic and renal metabolism of insulin in human subjects: a dose-response study. Am J Physiol. 1983;244(6):E517-27.
55. Pillonetto G, Sparacino G, Magni P, Bellazzi R, Cobelli C. Minimal model S(I)=0 problem in NIDDM subjects: nonzero Bayesian estimates with credible confidence intervals. Am J Physiol Endocrinol Metab. 2002;282(3):E564-73.
56. Eaton RP, Allen RC, Schade DS, Erickson KM, Standefer J. Prehepatic insulin production in man: kinetic analysis using peripheral connecting peptide behavior. J Clin Endocrinol Metab. 1980;51(3):520-8.
57. Van Cauter E, Mestrez F, Sturis J, Polonsky KS. Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes. 1992;41(3):368-77.